Xiamen Amoytop Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	371.82	412.96	301.24	285.42
Trading Asset Securities	-	289.96	257.08	270.78	196.38
Cash & Short-Term Investments	825.52	661.79	670.04	572.02	481.8
Cash Growth	24.74%	-1.23%	17.14%	18.73%	3.53%
Accounts Receivable	-	808.52	441.02	223.05	206.28
Other Receivables	-	22.34	17.87	20.17	21.67
Receivables	-	830.86	458.9	243.22	227.94
Inventory	-	263.55	187.02	129.73	116.49
Other Current Assets	-	70.9	24.24	10.64	8.19
Total Current Assets	-	1,827	1,340	955.61	834.42
Property, Plant & Equipment	-	686.76	490.85	389.77	192.92
Other Intangible Assets	-	170.85	191.54	121.69	146.91
Long-Term Deferred Tax Assets	-	69.09	43.66	47.18	34.96
Long-Term Deferred Charges	-	221.2	176.7	229.25	169.14
Other Long-Term Assets	-	75.35	112.98	26.05	44.99
Total Assets	-	3,050	2,356	1,770	1,424
Accounts Payable	-	57.76	39.73	50.91	8.14
Accrued Expenses	-	233.75	244.46	159.55	120.4
Short-Term Debt	-	-	-	-	10
Current Portion of Leases	-	5.67	4.16	4.18	5.79
Current Income Taxes Payable	-	50.27	48.95	41.97	24.42
Current Unearned Revenue	-	63.13	60.05	7.23	5.18
Other Current Liabilities	-	10.06	6.31	4.05	3.3
Total Current Liabilities	-	420.63	403.66	267.89	177.23
Long-Term Leases	-	3.27	3.76	5.56	9.37
Long-Term Unearned Revenue	-	32.96	40.62	47.68	51.25
Long-Term Deferred Tax Liabilities	-	0.93	0.41	15.15	5.54
Other Long-Term Liabilities	-	39.31	31.25	25.99	19.53
Total Liabilities	-	497.1	479.69	362.27	262.91
Common Stock	-	406.8	406.8	406.8	406.8
Additional Paid-In Capital	-	413.14	397.04	397.04	397.04
Retained Earnings	-	1,733	1,073	603.76	357.42
Shareholders' Equity	3,009	2,553	1,876	1,408	1,161
Total Liabilities & Equity	-	3,050	2,356	1,770	1,424
Total Debt	141.05	8.94	7.92	9.74	25.16
Net Cash (Debt)	684.47	652.85	662.11	562.28	456.63
Net Cash Growth	4.84%	-1.40%	17.76%	23.14%	2.28%
Net Cash Per Share	1.68	1.60	1.63	1.39	1.13
Filing Date Shares Outstanding	408.19	406.8	406.8	406.8	406.8
Total Common Shares Outstanding	408.19	406.8	406.8	406.8	406.8
Working Capital	-	1,406	936.53	687.72	657.19
Book Value Per Share	7.40	6.28	4.61	3.46	2.85
Tangible Book Value	2,566	2,382	1,685	1,286	1,014
Tangible Book Value Per Share	6.31	5.86	4.14	3.16	2.49
Buildings	-	291.61	135.53	118.65	21.31
Machinery	-	392.63	319.97	271.83	177.83
Construction In Progress	-	181.56	183.72	135.81	118

Source: S&P Global Market Intelligence. Standard template. Financial Sources.